TriNetX
  • Life Sciences
  • Healthcare
  • Drug Safety
    • Evidex Solutions
      • Signal Detection
      • Integrated Signal Management
      • Advanced Data Analytics
      • Drug Safety & Services
    • PV Library
      • GVP Module IX for Signal Management: The Complete Guide
      • Pharmacovigilance Signal Detection: The Complete Guide
  • Data
  • Products
    • Networks
      • LIVE Regional Networks
      • Linked Claims Network
      • Japan Claims Network
      • EVIDEX Signal Detection & Management
    • Features
      • Query Builder
      • TriNetX Connect
      • Base Analytics
      • Advanced Analytics
      • Follow the Patient
      • Bring Your Own Model
      • Diversity Lens
    • Data Sets
      • Curated Oncology
      • Linked Claims & EHR
      • Dataworks Enriched EHR
      • Open Claims
      • KOL Activity Reports
      • Bring Your Own Data
    • Consulting
      • Protocol feasibility and site identification
      • Chart Review
      • HEOR
      • Publications and Abstracts
      • Data Set Curation
      • Staff Augmentation
  • Resources
    • Webinars and Events
    • Publications
    • Case Studies
    • Blog
    • Press Releases
    • Coronavirus
  • About Us
    • Leadership
    • Board of Directors
    • Community
    • Careers
    • Contact Us
    • Ethics Hotline
  • Trust Center
  • Connect With Us
  • Sign In
Select Page

TriNetX Acquires Pharmacovigilance Leader Advera Health Analytics

Jan 21, 2022 | Press Releases

The world’s largest real-world data network takes aim at improving drug safety Cambridge, MA, January 21, 2022 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, today announced the...

TriNetX Launches Machine Learning Capabilities on Global Real-World Data

Jan 6, 2022 | Press Releases

Cambridge, MA, January 6, 2022 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, has announced the launch of its Bring Your Own Model (BYOM) product, a major step forward for the...

TriNetX Launches Diversity Lens Analytic to Improve Access to Clinical Trials for Underrepresented Patient Populations

Dec 9, 2021 | Press Releases

Cambridge, MA, December 9, 2021 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, has announced the launch of Diversity Lens, an analytic feature on the TriNetX platform which helps...

TriNetX and Advarra Partner to Provide Enhanced Site Selection Services

Nov 16, 2021 | Press Releases

Cambridge, MA, November 16, 2021 — TriNetX, the global health research network; and Advarra, the premier provider of independent review committees, quality and compliance consulting services, and research technology solutions; today announced a partnership that will...

TriNetX Announces the Appointment of Dr. Jeffrey Brown as Chief Scientific Officer

Nov 1, 2021 | Press Releases

Cambridge, MA, November 1, 2021 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, has announced that Jeffrey Brown, PhD, is joining the company as Chief Scientific Officer (CSO). Dr....

Colombia’s Clínica Imbanaco Joins the TriNetX Network to Increase International Research Collaboration

Oct 8, 2021 | Press Releases

Cambridge, MA, October 8, 2021 — Clínica Imbanaco, a leading research organization in Colombia, has joined the TriNetX network to maximize its research capacity and to expand its collaboration with other research sites around the world. Headquartered in Cali,...
« Older Entries
Next Entries »

TriNetX, LLC complies with all applicable privacy laws. For more information please visit our Trust Center.

ABOUT TRINETX, LLC

TriNetX is the global health research network that connects the world of drug discovery and development from pharmaceutical company to study site, and investigator to patient by sharing real-world data to make clinical and observational research easier and more efficient. TriNetX combines real time access to longitudinal clinical data with state-of-the-art analytics to optimize protocol design and feasibility, site selection, patient recruitment, and enable discoveries through the generation of real-world evidence. The TriNetX platform is HIPAA and GDPR compliant. For more information, visit TriNetX at www.trinetx.com or follow @TriNetX on Twitter.

Terms of Use
Privacy & Cookies

SIGN UP TO RECEIVE TRINETX COMMUNICATIONS

  • Twitter
©2022 TriNetX, LLC All Rights Reserved.